ALB · Albemarle Corporation
$133.702026-07-21Sector: Basic Materials; Industry: Chemicals - Specialty; Sub-Industry: Specialty Chemicals
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$0
-114.0% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($33 · $49) Analysts Range ($153 · $264) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $9.6B | — | 2.5% | 26.7% | $177MM | −$3.1B | −$2.9B | 10.7% | — | 1.4% | $13.0B | $13.27 | — |
| 2024.Q4 | $9.6B | 0.0% | 2.5% | 0.0% | $261MM | $227MM | $488MM | 11.9% | — | 2.1% | $12.3B | $13.27 | — |
| 2025.Q1 | $5.4B | -44.1% | -11.8% | 0.0% | −$690MM | $692MM | $1MM | 11.7% | — | -5.7% | $12.0B | $-9.94 | — |
| 2025.Q4 | $5.4B | 0.0% | -11.8% | 0.0% | −$960MM | $763MM | −$197MM | 13.0% | — | -8.3% | $11.1B | $-9.94 | — |
| 2026.Q1 | $5.5B | 2.2% | 5.6% | 0.0% | $864MM | $721MM | $1.6B | 10.6% | — | 7.9% | $10.6B | $-1.96 | 52.0 |
| italics below = DCF projection · 10yr Rev CAGR: 6.7% |
| 2027.Q1 | $6.4B | +16.8% | 5.5% | 2.0% | $349MM | −$893MM | −$544MM | 11.2% | −$489MM | 3.1% | $11.5B | $2.94 | 45.5 |
| 2028.Q1 | $6.8B | +5.3% | 7.0% | 4.0% | $451MM | −$395MM | $56MM | 10.9% | $46MM | 3.8% | $11.9B | $3.80 | 35.2 |
| 2029.Q1 | $7.1B | +5.1% | 8.4% | 6.0% | $558MM | −$505MM | $53MM | 10.7% | $39MM | 4.6% | $12.4B | $4.70 | 28.4 |
| 2030.Q1 | $7.5B | +5.0% | 9.8% | 8.0% | $670MM | $0MM | $670MM | 10.4% | $444MM | 5.4% | $12.4B | $5.65 | 23.7 |
| 2031.Q1 | $8.4B | +13.2% | 12.6% | 10.0% | $954MM | $0MM | $954MM | 10.2% | $575MM | 7.7% | $12.4B | $8.04 | 16.6 |
|
| Term. Yr+ | $10.9B | 4.1% | 12.6% | 20.0% | $1.1B | −$522MM | $573MM | 8.6% | $4.9B | 8.6% | — | — | — |
Active scenario IV: $0 (-114.0% vs market)